• Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at Johnson & Johnson...

  • Dec 10 2024
  • Length: 40 mins
  • Podcast

Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at Johnson & Johnson...

  • Summary

  • On today’s episode, meet Biljana Naumovic. Biljana is the President of U.S. Oncology, Solid Tumor at Johnson & Johnson, where she is spearheading innovative cancer treatments and advocating for equity in healthcare.

    She is committed to advancing the organization’s solid tumor portfolio and pipeline, spanning prostate, bladder, and lung cancer, as well as multiple novel treatment pathways. Biljana is passionately focused on bringing medical innovation and ultimately transforming patient care.

    Biljana is a physician by training and graduated in 2001 from the Belgrade University Medical School. She worked as a practicing physician for several years before transitioning to industry. She also holds an executive education degree from the London Business School.

    Send us a text

    researchevangelist.com

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at Johnson & Johnson...

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.